Located in a modern building at Poitiers University, our 40 lab members (clinicians, pharmacists and scientists) are conducting a multidisciplinary, translational and internationally recognized research.
The INSERM U1070 unit aims to optimize the antibiotic usage with a triple target: To increase their efficacy, to control the toxicity and to limit the emergence of antibiotic resistance. We are developing innovative PK/PD modelling approaches to select the best dosing regimen of antibiotics administered alone or in combination as well as the best route of administration and best formulation. Inserm U1070 conducts translational research, from cells culture to patients, by integrating microbiology, molecular biology, analytical chemistry, drug formulation, and in vivo preclinical experiments.
In our study of antibiotic PK/PD and antibiotic resistance, we have expanded our abilities to gather mechanistic data from multiple sources (conventional microbiology, molecular biology…) at high throughput.
The need to get new pre-clinical data on the emergence of antibiotic resistance is of high priority. Thus, we are looking for an experienced researcher willing to take on the challenge of developing new approaches for studying emergence of resistance during treatment. These approaches could include, but are not limited to:
This position will be funded through the ATIP/Avenir or the Junior Professor programs. Gross salary will range between 3450€ and 4200€ per month, depending on experience.
Funding for the research theme of the applicant:
Successful applicants will be expected to build their own group within our research unit. They will receive a generous welcome package worth 300 K€ to 400 K€ to recruit collaborators and fund equipment.
Technical support:
Access to experienced staff at core facilities and our own technical plateau.
Administrative assistance:
Help with formalities, including visas, insurance, and other necessary documents.
Personalized mentorship program:
Connecting you with experienced researchers for guidance.
Community integration:
Grand Poitiers will provide assistance in finding accommodation, a job for your spouse, schools for children, and other personal or family needs to facilitate your transition.
International recognition of Inserm U1070:
Several grants from ANR, PHRC, JPIAMR, IMI, and CPER-FEDER, along with established collaborations with universities in France and abroad, as well as leading pharmaceutical companies.
Access to clinical data:
Our team includes clinicians from the Poitiers university hospital (CHU), whose networks provide access to clinical data, particularly in infectiology and intensive care anesthesia.
Cutting-edge core facilities:
A bio-imaging platform, a modern BSL2 animal facility, a small animal inhalator, and an 80 m² BSL2 laboratory equipped with all necessary instruments, including a dedicated flow cytometer. Additionally, a molecular biology lab is available with PCR, qPCR, dPCR, and sequencing capabilities using Minion technology.
Interdisciplinary programs:
Funded by Poitiers University’s PIA « Excellence » program to provide financial support and opportunities to push the boundaries of knowledge.
Transdisciplinary and translational collaborations:
Partnerships between Poitiers University and CHU create opportunities to attract young trainees and foster collaborations with clinical medicine doctors through our local INSERM clinical investigation center.
Founded in 1431, it is one of Europe’s oldest universities. Located in a city rich in Art & History and known for its quality of life, the university’s strength lies in its strong links between Teaching and Research.
